We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients hospitalized with atrial fibrillation who ...

In patients with atrial fibrillation with low thrombosis risk but high bleeding risk, both standard- and low-dose DOACs are equally effective and safe. Standard-dose direct oral anticoagulant therapy ...

Use of half-dose direct oral anticoagulants (DOACs) showed promise as a long-term prophylactic strategy after successful percutaneous left atrial appendage (LAA) occlusion, according to an ...

After left atrial appendage (LAA) occlusion with the Watchman device (Boston Scientific), an antithrombotic strategy centered on a half-dose of a direct oral anticoagulant (DOAC) may improve outcomes ...

Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) dose that’s inconsistent with US Food and Drug Administration labeling—a practice believed, in many cases, to be ...

Despite concerns about the potential bleeding risk, IV thrombolysis could be safely given to ischemic stroke patients within a day of direct oral anticoagulant (DOAC) therapy, according to ...

(WASHINGTON, June 6, 2024) – Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes ...

Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes during the first three months ...

People with atrial fibrillation (Afib) who took low doses of blood-thinning drugs known as direct oral anticoagulants (DOACs) experienced more bleeding during the first three months of treatment.